Back
Monopar Therapeutics Vs. Greenbrier Companies Industry Stock Comparison
Buy
65
MNPR
Monopar Therapeutics
Last Price:
19.81
Seasonality Move:
7.43%
Buy
79
GBX
Greenbrier Companies
Last Price:
61.08
Seasonality Move:
-0.14%
Buy
65
Monopar Therapeutics (MNPR)
is a Buy
Is Monopar Therapeutics a Buy, Sell or Hold?
- The current Monopar Therapeutics [MNPR] share price is $32.66. The Score for MNPR is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
- MNPR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
79
Greenbrier Companies (GBX)
is a Buy
Is Greenbrier Companies a Buy, Sell or Hold?
- The current Greenbrier Companies [GBX] share price is $60.03. The Score for GBX is 79, which is 58% above its historic median score of 50, and infers lower risk than normal.
- GBX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
MNPR Stock Price Chart
What is Monopar Therapeutics's stock price today?
-
The Monopar Therapeutics share price today is $32.66
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MNPR is experiencing buying pressure, which is a positive indicator for future bullish movement.
GBX Stock Price Chart
What is Greenbrier Companies's stock price today?
-
The Greenbrier Companies share price today is $60.03
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GBX is experiencing buying pressure, which is a positive indicator for future bullish movement.
MNPR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.46 | Buy |
| Relative Strength Index (14 RSI): | 93.57 | Buy |
| Chaikin Money Flow: | 12436621 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.85 - 11.69) | Buy |
| Bollinger Bands (100): | (0.99 - 7.11) | Buy |
GBX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.51 | Buy |
| Relative Strength Index (14 RSI): | 78.56 | Buy |
| Chaikin Money Flow: | 1205681 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (48.94 - 53.2) | Buy |
| Bollinger Bands (100): | (46.29 - 51.51) | Buy |
MNPR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 8.64 | Buy |
| 20-day SMA: | 6.69 | Buy |
| 50-day SMA: | 4.51 | Buy |
| 200-day SMA: | 3.61 | Buy |
| 8-day EMA: | 11.25 | Buy |
| 20-day EMA: | 7.63 | Buy |
| 50-day EMA: | 5.48 | Buy |
| 200-day EMA: | 4.09 | Buy |
GBX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 53 | Buy |
| 20-day SMA: | 51.13 | Buy |
| 50-day SMA: | 49.09 | Buy |
| 200-day SMA: | 49.49 | Buy |
| 8-day EMA: | 53.48 | Buy |
| 20-day EMA: | 51.68 | Buy |
| 50-day EMA: | 50.04 | Buy |
| 200-day EMA: | 47.98 | Buy |
Monopar Therapeutics Earnings Growth & MNPR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.34 per share, and a decrease next year of $0.21 per share.
Greenbrier Companies Earnings Growth & GBX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.37 per share, and an increase next year of $0.78 per share.
Monopar Therapeutics Technical Analysis
| Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 10 | 11 | 14 | 15 | 16 | 18 | 21 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Greenbrier Companies Technical Analysis
| Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 10 | 11 | 14 | 15 | 16 | 18 | 21 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||